Cardiovascular

Two Steps Forward, One Step Back: 50 Years of Societal Value From LDL-C–Lowering Therapies

April 13th 2021, 1:00pm

Article

Low-density lipoprotein cholesterol (LDL-C)–lowering therapies have yielded significant value to society through reduced costs for both fatal and nonfatal cardiovascular disease events. The vast majority of this value has accrued to patients.

Clinical and Economic Outcomes of a Collaborative Cardiology Care Program

April 8th 2021, 4:00pm

Article

Patients with chronic cardiac conditions benefited from a health care program that strengthened collaboration between general practitioners and cardiology specialists in Baden-Wuerttemberg, Germany.

Early Intervention in Younger Patients With CAD Benefits Long-Term Prognosis

December 31st 2020, 12:00pm

Article

Premature coronary artery disease (CAD) is an aggressive disease with a high rate of ischemic recurrences and premature death, researchers said.

Top 5 Most-Read Conference Stories of 2020

December 29th 2020, 5:00pm

Article

The top 5 most-read conference stories of 2020 on AJMC.com included stories about study results on the impact that new therapies are having on cardiovascular and renal health.

Bleeding After DAPT Found to Be an Independent Predictor of Cardiovascular Events

December 28th 2020, 3:30pm

Article

A recent study sought to estimate the incidence of clinical events such as bleeding, myocardial infarction, and all-cause mortality in patients with acute myocardial infarction and chronic coronary syndrome who received dual antiplatelet therapy (DAPT) after coronary stenting.

ACC/AHA Clarify When AF Patients With Mitral Stenosis Should—And Should Not—Take DOACs

December 24th 2020, 3:00pm

Article

The distinction between valvular and nonvalvular atrial fibrillation (AF) has been a persistent point of confusion for clinicians.

New ACC Pathway in Atrial Fibrillation Calls for Limiting Aspirin

December 22nd 2020, 5:00am

Article

The American College of Cardiology provides new guidance on the best therapy to prevent blood clots for patients with atherosclerotic cardiovascular disease who also have atrial fibrillation or venous thromboembolism and require an anticoagulant.

Study Finds Vascepa Reduces Patient-Reported COVID-19 Symptoms

December 19th 2020, 11:30am

Article

Giving patients icosapent ethyl, or Vascepa, led to a 52% reduction of the total patient-reported symptom outcome prevalence score as compared with a 24% decline for outpatients who received usual care.

Cardiovascular Complications in Patients With Diabetes Drop in South Korea, Study Finds

December 18th 2020, 11:00pm

Article

There was a significant decrease in the rates of cardiovascular complications and mortality in adults with diabetes in South Korea, but other conditions increased.

Heavy Drinking Increases Risk of AF-Related Adverse Events

December 12th 2020, 12:00pm

Article

Despite heavy alcohol consumption being linked to increased incidence of atrial fibrillation (AF) and bleeding in patients with the condition, recommendations to control heavy drinking among this patient population are lacking.